Patents
Patents for C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
09/2004
09/14/2004US6790827 Bioconjugates and delivery of bioactive agents
09/08/2004EP1453888A1 Saccharide residue-functional organopolycarbosiloxanes and method for the preparation thereof
08/2004
08/31/2004US6783931 Amine-derivatized nucleosides and oligonucleosides
08/26/2004WO2004044215A3 Formulations comprising vitamin b12, method of production and use thereof
08/25/2004CN1524086A Process for producing methylcobalamin
08/18/2004EP1446440A1 Saccharide residue-functional organopolysiloxanes and method for the preparation thereof
08/17/2004US6777237 Bioconjugate comprises the bioactive agent and an organocobalt complex
08/17/2004US6776976 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues
08/04/2004EP1443051A2 Sugar modified oligonucleotides that detect and modulate gene expression
07/2004
07/28/2004EP1440077A1 Synthetic heparin pentasaccharides
07/22/2004US20040142899 Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals
07/14/2004EP1435973A1 Coadministration of transport protein with conjugated cobalamin to deliver agents
07/14/2004EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression
07/13/2004US6762289 Silicone functionalized alkyl polyglucoside surfactants
07/08/2004US20040132687 Process for producing methylcobalamin
06/2004
06/22/2004US6753423 For preferentially modulated gene expression in liver and associated tissues
06/16/2004EP1233772A4 Boron compounds and complexes as anti-inflammatory agents
06/09/2004EP1426380A1 Association compound of trehalose or maltitol with metal ion compound
05/2004
05/27/2004WO2004044215A2 Formulations comprising vitamin b12, method of production and use thereof
05/27/2004WO2003042283A8 Saccharide residue-functional organopolysiloxanes and method for the preparation thereof
05/27/2004US20040101890 Nucleic acid mediated electron transfer
05/12/2004EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression
04/2004
04/28/2004EP0777498B1 Conjugates made of metal complexes and oligonucleotides
04/14/2004EP1406914A2 Porphyrin derivatives for photodynamic therapy
04/01/2004US20040063925 Amplification; polymerase chain reaction
03/2004
03/31/2004EP1401850A1 Nucleoside derivatives for library preparation
03/31/2004EP0793668B1 Derivatives of carbohydrates and compositions containing them
03/18/2004US20040054128 Method of synthesis of beta-thiolato cobalamin compounds
03/17/2004EP0731807B1 N-2 substituted purines
03/11/2004US20040049008 Templated molecules and methods for using such molecules
03/11/2004US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/11/2004US20040048826 Oligonucleotides containing 2'-0-modified purines
03/04/2004US20040044190 Purification of oligomers
03/04/2004US20040040554 Binding of end groups to virus
03/03/2004EP1394174A1 Process for producing methylcobalamin
02/2004
02/19/2004WO2004014929A1 Derivatives of monosaccharides for drug discovery
02/19/2004US20040034203 Polyol-modified silanes as precursors for silica
02/19/2004US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality
02/19/2004CA2494677A1 Derivatives of monosaccharides for drug discovery
02/18/2004EP1389350A1 Nucleic acid circuit elements and methods
02/03/2004US6686463 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives
01/2004
01/14/2004CN1468234A Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
12/2003
12/31/2003WO2003078627A3 A building block capable of functional entity transfer to nucleophil
12/30/2003CA2172248C Self-sustained sequence replication electrochemiluminescent nucleic acid assay
12/18/2003WO2003078050A3 A building block forming a c-c bond upon reaction
12/16/2003CA2113894C A process for the preparation of demethylepypodophyllotoxin
12/11/2003WO2003102001A1 Polyol-modified silanes as precursors for silica
12/11/2003CA2486676A1 Polyol-modified silanes as precursors for silica
12/04/2003WO2003078626A3 A building block capable of transferring a functional entity
12/03/2003EP0973785B1 Trans-platinum compound, and diagnostic kit
12/02/2003US6657057 Generation of methylcobalamin; obtain cyanocobalamin or hydroxycobalamin, incubate with reducing agent and water-soluble methylating agent, recover methylcobalamin
11/2003
11/27/2003WO2003097647A1 Vitamin-mitomycin conjugates
11/12/2003EP1042344B1 Conductive metal-containing nucleic acids
11/11/2003US6646118 Solid phase synthesis
11/11/2003US6646114 Especially phosphorothioate oligonucleotides, and to intermediates used in that process; solution phase synthesis having improved efficiencies and enhanced convenience and cost
10/2003
10/29/2003EP0925306B1 Solid phase synthesis
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/16/2003US20030194705 Useful for coding and decoding complex mixtures of test units; non-standard nucleobases selectively base pair with other non-standard nucleobases
10/02/2003US20030187240 Nuclease resistant
09/2003
09/25/2003WO2003078627A2 A building block capable of functional entity transfer to nucleophil
09/25/2003WO2003078626A2 A building block capable of transferring a functional entity
09/25/2003WO2003078050A2 A building block forming a c-c bond upon reaction
09/18/2003US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis
09/17/2003EP0909184B1 Targeted drug delivery using sulfonamide derivatives
09/16/2003US6620926 Composition for use in the generation and purification of oligonucleotide sequences
09/12/2003WO2003074544A1 Methods of using unnatural nucleobases for decoding
09/11/2003US20030170677 Nucleic acid mediated electron transfer
09/03/2003EP1340764A2 Nucleic acid mediated electron transfer
09/02/2003US6613367 Complete nutrition of infants products are characterized by the type and amount of protein and carbohydrate and the increased levels of folic acid, vitamin B6 and vitamin B12 or their functional equivalents. These products improve feelings
09/02/2003US6613305 Radionuclide labeling of vitamin B12 and coenzymes thereof
08/2003
08/28/2003US20030162739 Antisense molecules and method of controlling expression of gene function by using the same
08/27/2003CN1438899A Ethylenedicysteine (EC)-drug conjugates
08/26/2003US6610663 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
08/13/2003EP1334114A2 Transcobalamin binding conjugates useful for treating abnormal cellular proliferation
08/12/2003US6605646 Vitamin supplement composition
08/05/2003CA2082934C Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents
07/2003
07/31/2003US20030144198 Increasing gastrointestinal absorption
07/31/2003US20030143561 Nucleoside derivatives for library preparation
07/30/2003EP1331011A2 Derivatized oligonucleotides having improved uptake and other properties
07/17/2003US20030135108 High throughput screening methods using magnetic resonance imaging agents
07/10/2003WO2003055898A1 Enzymatic redox labelling of nucleic acids
07/10/2003CA2471109A1 Enzymatic redox labelling of nucleic acids
06/2003
06/26/2003US20030120046 99m technetium, 188 and 186 rhenium chelated to 1-thio-d-glucose, glucosamine, or salts and hydrates thereof; tumor imaging agents
06/24/2003US6583122 Use in boron neutron capture therapy (BNCT) and diagnostic purposes; treating cancer, viral infections such as HIV, hepatitis B virus
06/24/2003US6582916 Compound for use as diagnostic tools in mass spectrometry
06/05/2003WO2003008430A3 Porphyrin derivatives for photodynamic therapy
06/04/2003EP0656037B1 Metal-mediated cross-coupling with ring-metalated porphyrins
05/2003
05/28/2003EP1313752A2 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives
05/22/2003WO2003042284A1 Saccharide residue-functional organopolycarbosiloxanes and method for the preparation thereof
05/22/2003WO2003042283A1 Saccharide residue-functional organopolysiloxanes and method for the preparation thereof
05/21/2003EP1268464A4 Radioisotope-labeled complexes of glucose derivatives and kits for the preparation thereof
05/20/2003US6566068 Process for detecting a nucleic acid of interest using an oligo- or polynucleotide probe and intercalators
05/07/2003EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins
05/07/2003EP1307446A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
05/07/2003EP0724447B1 Derivatized oligonucleotides having improved uptake
05/07/2003CN1107508C Method for prepn. of compsn. contg. 2,5-oligoadenylate derivatives
05/02/2003EP1173184A4 Rho-boronophenylalanine complexes with fructose and related carbohydrates and polyols
04/2003
04/23/2003EP0871642B1 Nucleic acid mediated electron transfer
04/16/2003EP1302475A1 Sugar chain-containing carbosilane dendrimer compounds, process for producing the same and verotoxin neutralizers and antiviral agents
04/16/2003EP1042345B1 Compounds for mass spectrometry comprising nucleic acid bases and aryl ether mass markers
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 18